MyAverix Finance
US · Healthcare
Mydecine Innovations Group Inc (MYCOF)
Drug Manufacturers - Specialty & Generic
Mydecine Innovations Group Inc (MYCOF) is listed on US in the Healthcare sector. Industry: Drug Manufacturers - Specialty & Generic. As of 2026-03-24, reported P/E ratio is 18.00. Use this page for a quick overview, then open the MyAverix Finance app for income statements, balance sheet, cash flow, and news.
Key metrics for MYCOF
Mydecine Innovations Group Inc (MYCOF) — FAQ
What is MYCOF's P/E ratio?
The price-to-earnings (P/E) ratio for Mydecine Innovations Group Inc (MYCOF) is 18.00 (data as of 2026-03-24).
Does Mydecine Innovations Group Inc pay a dividend?
Dividend yield is not available in the current snapshot for Mydecine Innovations Group Inc (MYCOF). Check the MyAverix Finance app for the latest dividend data.
What sector is Mydecine Innovations Group Inc in?
Mydecine Innovations Group Inc (MYCOF) is classified in the Healthcare sector (Drug Manufacturers - Specialty & Generic industry).
What exchange is MYCOF listed on?
MYCOF is listed on US.
Full report in the app
Get the full report in the MyAverix Finance app — income, balance sheet, cash flow, ratios, and multi-year trends in one place.